Earnings Call Open to Investors
Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys' corporate website at
www.synopsys.com. A recording of the call will be available by calling +1-800-770-2030 (+1-647-362-9199 for international callers), access code 6444570, beginning at 5:00 p.m. Pacific Time today, until 11:59 p.m. Pacific Time on December 7, 2022. A webcast replay will also be available on the corporate website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the first quarter fiscal year 2023 in February 2023. Synopsys will post copies of the prepared remarks on its website following today's call. In addition, Synopsys makes additional information available in a financial supplement and corporate overview presentation, also posted on the corporate website.
Effectiveness of Information
The targets included in this press release, the statements made during the earnings conference call and the information contained in the financial supplement and corporate overview presentation (available on Synopsys' corporate website at
www.synopsys.com) represent Synopsys' expectations and beliefs as of November 30, 2022. Although this press release, copies of the prepared remarks made during the call, the financial supplement, and the corporate overview presentation will remain available on Synopsys' website through the date of the earnings call for the first quarter fiscal year 2023, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys undertakes no duty and does not intend to update any forward-looking statement, whether as a result of new information or future events, or otherwise update, the targets given in this release unless required by law.
Availability of Final Financial Statements
Synopsys will include final financial statements for the fiscal year 2022 in its annual report on Form 10-K to be filed on or before December 28, 2022.
About Synopsys
Synopsys, Inc. (Nasdaq:
SNPS) is the Silicon to Software™ partner for innovative companies developing the electronic products and software applications we rely on every day. As an S&P 500 company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and offers the industry's broadest portfolio of application security testing tools and services. Whether you're a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing more secure, high-quality code, Synopsys has the solutions needed to deliver innovative products. Learn more at
www.synopsys.com.
GAAP to Non-GAAP Reconciliation
Synopsys continues to provide all information required in accordance with GAAP, but acknowledges evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys' operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal planning and forecasting purposes. These non-GAAP measures may be different from non-GAAP measures used by other companies. Synopsys' management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Synopsys' management believes it is useful for itself and investors to review, as applicable, both GAAP financial measures that include: (i) the amortization of acquired intangible assets, (ii) the impact of stock compensation, (iii) acquisition-related items, (iv) restructuring charges, (v) the effects of certain settlements, final judgments and loss contingencies related to legal proceedings, and (vi) the income tax effect of non-GAAP pre-tax adjustments; and the non-GAAP financial measures that exclude such information in order to assess the performance of Synopsys' business and for planning and forecasting in subsequent periods.
Synopsys adopted a three-year normalized non-GAAP tax rate of 16% for fiscal years 2019 through 2021 in calculating non-GAAP financial measures to provide better consistency across interim reporting periods by eliminating the effects of non-recurring and period-specific items, which can vary in size and frequency and do not necessarily reflect our normal operations, and to more closely align our tax rate with our expected geographic earnings mix.
Synopsys adopted an annual non-GAAP tax rate of 18% for fiscal year 2022 and given uncertainty surrounding further U.S. corporate tax law changes, has elected to maintain a non-GAAP tax rate of 18% for fiscal year 2023 rather than adopt a three-year normalized non-GAAP tax rate in calculating its non-GAAP financial measures. This annual non-GAAP tax rate is based on an evaluation of its historical and projected mix of U.S. and international profit before tax, taking into account the impact of non-GAAP adjustments, U.S. tax law changes, as well as other factors such as its current tax structure, existing tax positions and expected recurring tax incentives. Synopsys re-evaluates this rate on a periodic basis for any significant events that could materially affect its projections, such as significant changes in its geographic earnings mix or significant tax law changes in major jurisdictions where Synopsys operates, and will further consider the appropriateness of adopting a multi-year normalized non-GAAP tax rate. When possible, Synopsys provides a reconciliation of the non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed below, as well as Item 2.02 of Synopsys' Current Report on Form 8-K filed on November 30, 2022, for additional information about the measures Synopsys uses to evaluate its core business operations. Synopsys is unable to provide a reconciliation of certain non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis because doing so would not be possible without unreasonable effort due to, among other things, the potential variability and limited visibility of the excluded items.
Reconciliation of Fourth Quarter and Fiscal Year 2022 Results
The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income and earnings per diluted share for the periods indicated below.
GAAP to Non-GAAP Reconciliation of Fourth Quarter and Fiscal Year 2022 Results (1) | |||||||
(unaudited and in thousands, except per share amounts) | |||||||
| |||||||
| Three Months Ended |
| Twelve Months Ended | ||||
| October 31, |
| October 31, | ||||
| 2022 |
| 2021 |
| 2022 |
| 2021 |
GAAP net income | $ 153,500 |
| $ 201,447 |
| $ 984,594 |
| $ 757,516 |
Adjustments: |
|
|
|
|
|
|
|
Amortization of intangible assets | 25,530 |
| 21,943 |
| 95,711 |
| 82,380 |
Stock compensation | 125,339 |
| 96,742 |
| 458,776 |
| 345,272 |
Acquisition-related items | (2,063) |
| 3,800 |
| 9,269 |
| 15,394 |
Restructuring charges | - |
| 18,254 |
| 12,057 |
| 33,405 |
Legal matters | - |
| - |
| - |
| (1,455) |
Tax adjustments | (4,618) |
| (56,430) |
| (167,582) |
| (155,727) |
Non-GAAP net income | $ 297,688 |
| $ 285,756 |
| $ 1,392,825 |
| $ 1,076,785 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Three Months Ended |
| Twelve Months Ended | ||||
| October 31, |
| October 31, | ||||
| 2022 |
| 2021 |
| 2022 |
| 2021 |
GAAP net income per diluted share | $ 0.99 |
| $ 1.28 |
| $ 6.29 |
| $ 4.81 |
Adjustments: |
|
|
|
|
|
|
|
Amortization of intangible assets | 0.16 |
| 0.14 |
| 0.61 |
| 0.52 |
Stock compensation | 0.80 |
| 0.62 |
| 2.93 |
| 2.19 |
Acquisition-related items | (0.01) |
| 0.02 |
| 0.06 |
| 0.10 |
Restructuring charges | - |
| 0.12 |
| 0.08 |
| 0.21 |
Legal matters | - |
| - |
| - |
| (0.01) |
Tax adjustments | (0.03) |
| (0.36) |
| (1.07) |
| (0.98) |
Non-GAAP net income per diluted share | $ 1.91 |
| $ 1.82 |
| $ 8.90 |
| $ 6.84 |
|
|
|
|
|
|
|
|
Shares used in computing net income per diluted share amounts: | 155,749 |
| 157,243 |
| 156,485 |
| 157,340 |
|
|
|
|
|
|
|
|
(1) Synopsys' fourth quarter of fiscal year 2022 and 2021 ended on October 29, 2022 and October 30, 2021, respectively. For
|